GlobeImmune's Series B Round

GlobeImmune raised a round of funding on , .

GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to…

Articles about GlobeImmune's Series B Round: